tiprankstipranks
Humacyte (HUMA)
NASDAQ:HUMA
US Market
HUMA
Humacyte
RESEARCH TOOLSreports

Humacyte (HUMA) Ratios

1,615 Followers

Humacyte Ratios

HUMA's free cash flow for Q4 2025 was $-26.27. For the 2025 fiscal year, HUMA's free cash flow was decreased by $ and operating cash flow was $-213.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.69 3.69 2.40 4.52 7.88
Quick Ratio
 2.95 2.95 2.40 4.52 7.88
Cash Ratio
 2.75 2.75 2.25 4.36 7.65
Solvency Ratio
 -0.30 -0.30 -0.74 -0.90 -0.04
Operating Cash Flow Ratio
 -5.72 -5.72 -4.92 -3.97 -3.63
Short-Term Operating Cash Flow Coverage
 -43.26 -43.26 0.00 0.00 -8.30
Net Current Asset Value
$ -45.46M$ -45.46M$ -142.68M$ -31.40M$ 66.83M
Leverage Ratios
Debt-to-Assets Ratio
 0.56 0.56 0.12 0.45 0.25
Debt-to-Equity Ratio
 20.86 20.86 -0.31 4.24 0.43
Debt-to-Capital Ratio
 0.95 0.95 -0.46 0.81 0.30
Long-Term Debt-to-Capital Ratio
 0.92 0.92 0.00 0.74 0.15
Financial Leverage Ratio
 37.43 37.43 -2.62 9.47 1.75
Debt Service Coverage Ratio
 -7.32 -7.32 -14.25 -14.62 -5.17
Interest Coverage Ratio
 -9.55 -9.55 -12.33 -15.16 -13.64
Debt to Market Cap
 0.41 0.25 0.00 0.13 0.13
Interest Debt Per Share
 0.48 0.48 0.22 0.62 0.55
Net Debt to EBITDA
 -0.14 -0.14 0.21 0.24 1.31
Profitability Margins
Gross Profit Margin
-736.46%-736.46%0.00%0.00%-427.48%
EBIT Margin
-5271.69%-5271.69%0.00%0.00%-5404.35%
EBITDA Margin
-4911.29%-4911.29%0.00%0.00%-4879.74%
Operating Profit Margin
-5271.69%-5271.69%0.00%0.00%-5404.35%
Pretax Profit Margin
-2003.58%-2003.58%0.00%0.00%-764.54%
Net Profit Margin
-2003.58%-2003.58%0.00%0.00%-764.54%
Continuous Operations Profit Margin
-2003.58%-2003.58%0.00%0.00%-764.54%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
38.01%38.01%129.99%110.72%14.15%
Return on Assets (ROA)
-35.09%-35.09%-107.85%-86.39%-5.86%
Return on Equity (ROE)
-424.76%-1313.38%282.33%-817.78%-10.23%
Return on Capital Employed (ROCE)
-109.64%-109.64%-97.01%-91.13%-45.79%
Return on Invested Capital (ROIC)
-106.99%-106.99%-94.67%-89.06%-43.24%
Return on Tangible Assets
-35.09%-35.09%-107.85%-86.39%-5.86%
Earnings Yield
-43.62%-26.88%-24.85%-37.72%-5.50%
Efficiency Ratios
Receivables Turnover
 4.62 4.62 0.00 0.00 50.48
Payables Turnover
 3.15 3.15 1.60 11.80 5.18
Inventory Turnover
 1.25 1.25 0.00 0.00 0.00
Fixed Asset Turnover
 0.04 0.04 0.00 0.00 0.03
Asset Turnover
 0.02 0.02 0.00 0.00 <0.01
Working Capital Turnover Ratio
 0.06 0.05 0.00 0.00 <0.01
Cash Conversion Cycle
 254.23 254.23 -227.93 -30.95 -63.29
Days of Sales Outstanding
 78.98 78.98 0.00 0.00 7.23
Days of Inventory Outstanding
 290.96 290.96 0.00 0.00 0.00
Days of Payables Outstanding
 115.71 115.71 227.93 30.95 70.52
Operating Cycle
 369.94 369.94 0.00 0.00 7.23
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.66 -0.66 -0.83 -0.71 -0.69
Free Cash Flow Per Share
 -0.67 -0.67 -0.84 -0.73 -0.70
CapEx Per Share
 <0.01 <0.01 0.01 0.02 0.01
Free Cash Flow to Operating Cash Flow
 1.01 1.01 1.02 1.03 1.01
Dividend Paid and CapEx Coverage Ratio
 -118.83 -118.83 -62.42 -32.15 -67.87
Capital Expenditure Coverage Ratio
 -118.83 -118.83 -62.42 -32.15 -67.87
Operating Cash Flow Coverage Ratio
 -1.62 -1.62 -5.93 -1.28 -1.42
Operating Cash Flow to Sales Ratio
 -51.54 -51.54 0.00 0.00 -45.45
Free Cash Flow Yield
-114.15%-69.73%-16.66%-25.73%-33.19%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.29 -3.72 -4.02 -2.65 -18.17
Price-to-Sales (P/S) Ratio
 45.53 74.54 0.00 0.00 138.94
Price-to-Book (P/B) Ratio
 30.11 48.86 -11.36 21.68 1.86
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.88 -1.43 -6.00 -3.89 -3.01
Price-to-Operating Cash Flow Ratio
 -0.89 -1.45 -6.10 -4.01 -3.06
Price-to-Earnings Growth (PEG) Ratio
 -0.53 0.05 -0.23 >-0.01 0.22
Price-to-Fair Value
 30.11 48.86 -11.36 21.68 1.86
Enterprise Value Multiple
 -1.07 -1.66 -4.31 -2.81 -1.54
Enterprise Value
 107.14M 166.26M 569.92M 270.72M 117.73M
EV to EBITDA
 -1.07 -1.66 -4.31 -2.81 -1.54
EV to Sales
 52.57 81.58 0.00 0.00 75.23
EV to Free Cash Flow
 -1.01 -1.57 -5.72 -3.58 -1.63
EV to Operating Cash Flow
 -1.02 -1.58 -5.81 -3.69 -1.66
Tangible Book Value Per Share
 0.02 0.02 -0.44 0.13 1.13
Shareholders’ Equity Per Share
 0.02 0.02 -0.44 0.13 1.13
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.01 0.01 0.00 0.00 0.02
Net Income Per Share
 -0.26 -0.26 -1.26 -1.07 -0.12
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.38 0.38 1.07 1.06 0.14
Research & Development to Revenue
 34.00 34.00 0.00 0.00 40.42
SG&A to Revenue
 14.42 15.29 0.00 0.00 14.62
Stock-Based Compensation to Revenue
 4.79 4.79 0.00 0.00 3.95
Income Quality
 2.57 2.57 0.66 0.66 5.94
Currency in USD